Shares in Mylan (NSDQ:MYL) fell yesterday after the company missed earnings expectations but beat sales estimates on Wall Street with its fourth-quarter financial results.
The Pittsburgh, PA-based company posted profits of $51.2 million, or 10¢ per share, on sales of $3.04 billion for the three months ended Dec. 31, for bottom-line loss of -79% on sales loss of -5% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Mylan shares down on mixed Q4 results appeared first on MassDevice.
from MassDevice https://ift.tt/2ThP3h6
Cap comentari:
Publica un comentari a l'entrada